We are live on
!
Find out more
Thrivent Financial for Lutherans Portfolio holdings
AUM
$52.5B
1-Year Est. Return
27.12%
This Fund
S&P 500
This Quarter
Est. Return
-14.49%
1 Year Est. Return
+27.12%
3 Year Est. Return
+79.38%
5 Year Est. Return
+100.59%
10 Year Est. Return
+446.23%
AUM
$37.5B
AUM Growth
-$13.6B
(-27%)
Cap. Flow
-$5.63B
Cap. Flow
% of AUM
-15%
Top 10 Holdings %
Top 10 Hldgs %
13.76%
Holding
2,591
New
98
Increased
1,277
Reduced
945
Closed
185
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$217M |
| 2 |
Casey's General Stores
CASY
|
+$114M |
| 3 |
Nike
NKE
|
+$98.8M |
| 4 |
Warner Bros
WBD
|
+$98.3M |
| 5 |
HR
Healthcare Realty Trust Incorporated
HR
|
+$85.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vident US Equity Strategy ETF
VUSE
|
+$429M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
+$395M |
| 3 |
Vident International Equity Strategy
VIDI
|
+$393M |
| 4 |
Vident US Bond Strategy ETF
VBND
|
+$371M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 11.8% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Inogen
INGN
$164M
| $488K | ﹤0.01% |
20,191
+3,542
| +21% | +$94.1K |
|
2027
OptimizeRx
OPRX
$133M
| $488K | ﹤0.01% |
17,834
+3,368
| +23% | +$99.8K |
|
|
WSR
2028
DELISTED
Whitestone REIT
WSR
| $488K | ﹤0.01% |
45,388
+7,805
| +21% | +$93.8K |
|
|
EGRX
2029
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $488K | ﹤0.01% |
10,979
+1,728
| +19% | +$79.4K |
|
|
EMD
2030
Western Asset Emerging Markets Debt Fund
EMD
$616M
| $486K | ﹤0.01% |
55,083
+5,000
| +10% | +$48.1K |
|
2031
908 Devices
MASS
$364M
| $483K | ﹤0.01% |
23,470
| – | – |
|
2032
Vanguard Communication Services ETF
VOX
$5.85B
| $481K | ﹤0.01% |
5,115
+1,777
| +53% | +$185K |
|
|
UBA
2033
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $480K | ﹤0.01% |
29,632
+5,079
| +21% | +$87.8K |
|
2034
Tronox
TROX
$1.04B
| $479K | ﹤0.01% |
28,550
| – | – |
|
2035
iShares Semiconductor ETF
SOXX
$45.9B
| $478K | ﹤0.01% |
4,101
-798
| -16% | -$108K |
|
2036
PC Connection
CNXN
$2.12B
| $477K | ﹤0.01% |
10,839
+1,878
| +21% | +$89.1K |
|
|
IAE
2037
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$93.1M
| $476K | ﹤0.01% |
68,450
-4,000
| -6% | -$29K |
|
2038
LendingTree
TREE
$451M
| $473K | ﹤0.01% |
10,786
+1,450
| +16% | +$107K |
|
2039
Koppers
KOP
$969M
| $470K | ﹤0.01% |
20,772
+745
| +4% | +$18.9K |
|
2040
Everest Group
EG
$14.4B
| $469K | ﹤0.01% |
1,674
+9
| +0.5% | +$2.54K |
|
2041
Atlassian
TEAM
$37.8B
| $466K | ﹤0.01% |
2,487
-892
| -26% | -$190K |
|
2042
XPeng
XPEV
$11.6B
| $464K | ﹤0.01% |
14,624
| – | – |
|
|
TBRG
2043
DELISTED
TruBridge
TBRG
| $464K | ﹤0.01% |
14,505
+2,580
| +22% | +$83.5K |
|
2044
ARK Genomic Revolution ETF
ARKG
$1.73B
| $463K | ﹤0.01% |
14,697
+4,488
| +44% | +$157K |
|
2045
Nordson
NDSN
$17.3B
| $463K | ﹤0.01% |
2,287
-13,166
| -85% | -$2.81M |
|
2046
Kyndryl
KD
$3.05B
| $461K | ﹤0.01% |
47,129
+274
| +0.6% | +$3.19K |
|
|
IPG
2047
DELISTED
Interpublic Group of Companies
IPG
| $460K | ﹤0.01% |
16,706
-8,609
| -34% | -$273K |
|
2048
Vanguard ESG US Stock ETF
ESGV
$13.7B
| $458K | ﹤0.01% |
6,901
+1,693
| +33% | +$122K |
|
2049
Coherus Oncology
CHRS
$196M
| $457K | ﹤0.01% |
63,134
+11,252
| +22% | +$97.8K |
|
2050
American Eagle Outfitters
AEO
$3.01B
| $452K | ﹤0.01% |
40,411
+314
| +0.8% | +$4.43K |
|
Similar funds
SCP
Thrivent Financial for Lutherans's Q2 2022 Portfolio in Review
As of Q2 2022, Thrivent Financial for Lutherans held 2,591 positions worth $37.5B, down 27% from $51.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Thrivent Financial for Lutherans withdrew a net $5.63B in Q2 2022, closing 185 positions and reducing 945 holdings. Its most notable exit was Vident US Equity Strategy ETF, an estimated $429M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Thrivent Financial for Lutherans opened a new position in Janus International worth $27.3M.
- Thrivent Financial for Lutherans's largest Q2 2022 buy was Janus International: 3,021,252 shares worth $27.3M.
- Thrivent Financial for Lutherans added most to Labcorp in Q2 2022, an estimated $217M increase.
- Thrivent Financial for Lutherans's biggest Q2 2022 reduction was iShares Core S&P US Value ETF, cutting an estimated $395M.
- Thrivent Financial for Lutherans fully exited Vident US Equity Strategy ETF in Q2 2022, selling an estimated $429M.
- Thrivent Financial for Lutherans's ten largest holdings make up 14% of its $37.5B portfolio in Q2 2022.
- Thrivent Financial for Lutherans opened 98 new positions and closed 185 in Q2 2022.
- Thrivent Financial for Lutherans's portfolio value fell 27% quarter-over-quarter to $37.5B.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2022, filed 16 Aug 2022.